| RS1024610 |
CCL2
|
Protective |
protective |
Susceptibility to HIV infection, Susceptibility to HIV infection |
| RS1042669 |
MGST1
|
Protective |
protective |
Pulmonary disease, chronic obstructive |
| RS1050501 |
FCGR2B
|
Protective |
protective; risk factor |
Systemic lupus erythematosus, susceptibility to |
| RS1063192 |
CDKN2B;CDKN2B-AS1
|
Protective |
Likely pathogenic; protective |
Three Vessel Coronary Disease, Malignant tumor of breast |
| RS11048977 |
BMAL2
|
Protective |
protective |
Pulmonary disease, chronic obstructive |
| RS11739136 |
KCNMB1
|
Protective |
Benign; protective |
HYPERTENSION, DIASTOLIC |
| RS121912426 |
IGF1R
|
Protective |
protective |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS121912427 |
IGF1R
|
Protective |
protective |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS121912428 |
IGF1R
|
Protective |
protective |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1229984 |
ADH1B
|
Protective |
protective |
Aerodigestive tract cancer, squamous cell |
| RS1253103806 |
IGF1R
|
Protective |
protective |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1333042 |
CDKN2B-AS1
|
Protective |
protective |
Three Vessel Coronary Disease, Three Vessel Coronary Disease |
| RS1409058783 |
IGF1R
|
Protective |
protective |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1555460945 |
IGF1R
|
Protective |
protective |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS1693482 |
ADH1C
|
Protective |
protective |
Alcohol dependence, Alcohol dependence |
| RS1755646498 |
SLC6A3
|
Protective |
protective |
Nicotine dependence, protection against |
| RS1799864 |
CCR2
|
Protective |
Benign; protective |
Susceptibility to HIV infection, CCR2-related disorder |
| RS1799987 |
CCR5
|
Protective |
Conflicting classifications of pathogenicity; protective |
Acquired immunodeficiency syndrome, delayed progression to |
| RS1800482 |
NOS2
|
Protective |
protective |
Malaria, severe |
| RS1800560 |
CCR5
|
Protective |
protective |
Susceptibility to HIV infection, Susceptibility to HIV infection |
| RS1800630 |
TNF
|
Protective |
protective |
Alzheimer disease, protection against |
| RS1800940 |
CCR5
|
Protective |
protective |
Susceptibility to HIV infection, Susceptibility to HIV infection |
| RS1801708 |
EDNRA
|
Protective |
protective |
Migraine, resistance to |
| RS200185429 |
SLC30A8
|
Protective |
protective |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS2066702 |
ADH1B
|
Protective |
protective |
Alcohol dependence, Alcohol dependence |
| RS2070744 |
NOS3
|
Protective |
protective |
Metabolic syndrome, susceptibility to |
| RS2120749035 |
IFNG
|
Protective |
protective |
Mycobacterium tuberculosis, protection against |
| RS2131902 |
ADAR
|
Protective |
protective |
Colorectal cancer, Colorectal cancer |
| RS2168101 |
LMO1
|
Protective |
Benign; protective |
LMO1 POLYMORPHISM, Neuroblastoma |
| RS2274567 |
CR1
|
Protective |
Benign; protective |
Malaria, severe |
| RS2333227 |
MPO
|
Protective |
protective; risk factor |
Lung cancer, protection against |
| RS267606980 |
PRNP
|
Protective |
protective |
Kuru, protection against |
| RS267607133 |
TOP2A
|
Protective |
protective |
Dna topoisomerase II, resistance to inhibition of |
| RS2857657 |
CCL2
|
Protective |
protective |
Susceptibility to HIV infection, Susceptibility to HIV infection |
| RS3742377 |
CYP46A1
|
Protective |
protective |
Pulmonary disease, chronic obstructive |
| RS3834129 |
CASP8
|
Protective |
protective |
Lung cancer, protection against |
| RS387906400 |
CXCL12
|
Protective |
protective |
Susceptibility to HIV infection, Susceptibility to HIV infection |
| RS4147611 |
MGST3
|
Protective |
protective |
Pulmonary disease, chronic obstructive |
| RS4795895 |
CCL11
|
Protective |
protective |
Susceptibility to HIV infection, Susceptibility to HIV infection |
| RS4804803 |
CD209
|
Protective |
protective; risk factor |
Susceptibility to HIV infection, Mycobacterium tuberculosis |
| RS547154 |
C2
|
Protective |
protective |
Age related macular degeneration 14, Age related macular degeneration 14 |
| RS5743618 |
TLR1
|
Protective |
Conflicting classifications of pathogenicity; protective |
Leprosy, protection against |
| RS5743810 |
TLR6
|
Protective |
protective |
Leprosy, susceptibility to |
| RS5744168 |
TLR5
|
Protective |
protective; risk factor |
Legionnaire disease, susceptibility to |
| RS587777582 |
SLC30A8
|
Protective |
protective |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS61734659 |
PRSS2
|
Protective |
protective |
Pancreatitis, chronic |
| RS698 |
ADH1C
|
Protective |
protective |
Alcohol dependence, Alcohol dependence |
| RS9282799 |
NOS2
|
Protective |
protective |
Malaria, resistance to |
| RS9332959 |
MGST1
|
Protective |
protective |
Pulmonary disease, chronic obstructive |
| RS9632884 |
CDKN2B-AS1
|
Protective |
protective |
Three Vessel Coronary Disease, Three Vessel Coronary Disease |